Swedish Orphan Biovitrum Ab (publ)
(OTC) BIOVF
Swedish Orphan Biovitrum Ab (publ) Financials at a Glance
Market Cap
$14.28B
Revenue (TTM)
$28.16B
Net Income (TTM)
$493.33M
EPS (TTM)
$0.11
P/E Ratio
342.34
Dividend
$0.00
Beta (Volatility)
0.17 (Low)
Dividend
$0.00
Beta (Volatility)
0.17 (Low)
Price
$41.32
Volume
345
Open
$42.22
Price
$41.32
Volume
345
Open
$42.22
Previous Close
$41.32
Daily Range
$41.32 - $42.22
52-Week Range
$25.80 - $42.22
Dividend
$0.00
Beta (Volatility)
0.17 (Low)
Price
$41.32
Volume
345
Open
$42.22
Previous Close
$41.32
Daily Range
$41.32 - $42.22
52-Week Range
$25.80 - $42.22
BIOVF News
BIOVF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Swedish Orphan Biovitrum Ab (publ)
Industry
Biotechnology
Sector
Health CareEmployees
1,888
CEO
Guido Oelkers, PhD
Website
www.sobi.comHeadquarters
Solna, 112 76, SE
BIOVF Financials
Key Financial Metrics (TTM)
Gross Margin
44%
Operating Margin
29%
Net Income Margin
2%
Return on Equity
1%
Return on Capital
16%
Return on Assets
1%
Earnings Yield
0.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.28B
Shares Outstanding
345.66M
Volume
345
Short Interest
0.00%
Avg. Volume
18.541
Financials (TTM)
Gross Profit
$12.29B
Operating Income
$8.03B
EBITDA
$10.94B
Operating Cash Flow
$8.54B
Capital Expenditure
$39.90M
Free Cash Flow
$8.50B
Cash & ST Invst.
$1.04B
Total Debt
$11.72B
Swedish Orphan Biovitrum Ab (publ) Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.80B
+4.9%
Gross Profit
$5.58B
-4.5%
Gross Margin
71.47%
N/A
Market Cap
$14.28B
N/A
Market Cap/Employee
$7.54M
N/A
Employees
1,895
N/A
Net Income
$1.86B
+33.0%
EBITDA
$3.13B
+20.8%
Quarterly Fundamentals
Net Cash
$10.69B
+31.5%
Accounts Receivable
$8.34B
+6.1%
Inventory
$5.11B
+23.0%
Long Term Debt
$5.68B
-55.2%
Short Term Debt
$6.04B
+48.8%
Return on Assets
0.71%
N/A
Return on Invested Capital
15.67%
N/A
Free Cash Flow
$2.97B
+70.9%
Operating Cash Flow
$2.97B
+65.4%